Evidence map›Paper›PMID 30546399›Full record

ArticleExperimental and therapeutic medicine2018

Quantum dot-based fluorescent probes for targeted imaging of the EJ human bladder urothelial cancer cell line.

Run Yuan, Ting Rao, Fan Cheng, Wei-Min Yu, Yuan Ruan, Xiao-Bin Zhang, Stéphane Larré

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Nanoparticle-Based Techniques for Bladder Cancer Imaging: A Review.International journal of molecular sciences · 2023
    Review
  2. Article
  3. Current applications of nanomaterials in urinary system tumors.Frontiers in bioengineering and biotechnology · 2023
    Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Run YuanDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Ting RaoDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Fan ChengDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Wei-Min YuDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Yuan RuanDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Xiao-Bin ZhangDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Stéphane LarréDepartment of Urology, Robert Debré Teaching Hospital, University of Reims, 51100 Reims, France.
Renmin Hospital of Wuhan University · CNUniversité de Reims Champagne-Ardenne · FRWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

QDs are a type of inorganic nanoparticle with unique optical properties. As a fluorescent label, QDs are widely used in biomedical fields. In the present study, fluorescent probes of quantum dots (QDs) conjugated with a prostate stem cell antigen (PSCA) monoclonal antibody (QD-PSCA) were prepared to study the targeted imaging of QD-PSCA probes in EJ human bladder urothelial cancer cells and analyze the feasibility of QD-based non-invasive tumor-targeted imaging

Indexed as

bladder cancerfluorescent probesPSCAquantum dots

Identifiers

PMID30546399
PMCPMC6256864
OpenAlexW2893251959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.